Published in Schmerz on April 01, 2005
[Addition is also a disease]. Schmerz (2008) 0.88
[Accidental levomethadone intoxication in a palliative patient]. Schmerz (2012) 0.78
[Insertion techniques for intrathecal pain therapy]. Schmerz (2005) 0.75
[Perispinal pain therapy. How invasive should we be?]. Schmerz (2007) 0.75
[Risk minimization in pain therapy: important target but how can it be reached?]. Schmerz (2008) 0.75
[Dependency syndrome and hyperalgesia due to an opioid therapy for curative treatable pain. Case report of an apparent palliative patient]. Schmerz (2013) 0.75
Why we need observational studies to evaluate the effectiveness of health care. BMJ (1996) 17.27
Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity, and survival. J Clin Oncol (2002) 3.25
A prospective study of catheter-related complications of intrathecal drug delivery systems. J Pain Symptom Manage (2000) 1.61
Piriformis syndrome. Orthopedics (2002) 1.55
Long-term spinal analgesic delivery: a review of the preclinical and clinical literature. Reg Anesth Pain Med (2000) 1.51
Spinal cord compression by catheter granulomas in high-dose intrathecal morphine therapy: case report. Neurosurgery (1998) 1.49
Intrathecal baclofen for spasticity of spinal origin: seven years of experience. J Neurosurg (1992) 1.48
Long-term opioid analgesic therapy for severe refractory lumbar spine pain. Clin J Pain (1999) 1.44
Assessment of cancer pain: a prospective evaluation in 2266 cancer patients referred to a pain service. Pain (1996) 1.37
Intrathecal baclofen for intractable spasticity of spinal origin: results of a long-term multicenter study. J Neurosurg (1993) 1.36
How response shift may affect the measurement of change in fatigue. J Pain Symptom Manage (2000) 1.11
Complications of intrathecal baclofen delivery. Br J Neurosurg (1992) 1.11
Chronic intrathecal infusions after spinal cord injury cause scarring and compression. Microsc Res Tech (2001) 1.04
[Postoperative pain therapy in Germany]. Anaesthesist (2002) 1.02
Long-term effects of continuous intrathecal opioid treatment in chronic pain of nonmalignant etiology. J Neurosurg (1996) 1.01
A prospective study of long-term intrathecal morphine in the management of chronic nonmalignant pain. Neurosurgery (1999) 0.99
Treatment of chronic pain by using intrathecal drug therapy compared with conventional pain therapies: a cost-effectiveness analysis. J Neurosurg (2002) 0.95
[Guidelines -- safety net]. Schmerz (2003) 0.93
Continuous intrathecal morphine treatment for chronic pain of nonmalignant etiology: long-term benefits and efficacy. Surg Neurol (2001) 0.88
Staphylococcal meningitis following Synchromed intrathecal pump implant: a case report. Pain (1994) 0.86
Clinical guidelines for intraspinal infusion: report of an expert panel. PolyAnalgesic Consensus Conference 2000. J Pain Symptom Manage (2000) 0.85
Radioisotopic control for baclofen pump catheter failure. Spinal Cord (2001) 0.85
Catheter systems for intrathecal drug delivery. J Neurosurg (1995) 0.84
Cranial nerve palsy and intracranial subdural hematoma following implantation of intrathecal drug delivery device. Reg Anesth Pain Med (2000) 0.82
Long-term intraspinal infusions of opioids in the treatment of neuropathic pain. J Pain Symptom Manage (1995) 0.81
[Morphine tablets for chronic non-tumor-induced pain. Which factors modify the success or failure of a long-term therapy?]. Anaesthesist (1993) 0.81
Spinal cord compression by catheter granulomas in high-dose intrathecal morphine therapy: case report. Neurosurgery (1999) 0.80
Neuromodulation of pain. A consensus statement prepared in Brussels 16-18 January 1998 by the following task force of the European Federation of IASP Chapters (EFIC). Eur J Pain (1998) 0.80
[Standardization of invasive neuromodulatory procedures]. Schmerz (2003) 0.79
Clinical realities and economic considerations: efficacy of intrathecal pain therapy. J Pain Symptom Manage (1997) 0.79
Intraventricular administration of morphine for control of intractable cancer pain in 90 patients. Neurosurgery (1996) 0.79
Intrathecal granuloma after implantation of a morphine pump: case report and review of the literature. Surg Neurol (1997) 0.79
Neurologic sequelae of intraspinal drug delivery systems: results of a survey of american implanters of implantable drug delivery systems. Neuromodulation (1998) 0.78
[Transverse myelopathy as a complication following long-term intrathecal application of morphine in chronic back pain]. Anasthesiol Intensivmed Notfallmed Schmerzther (1999) 0.78
Extradural blood patch of a cerebrospinal fluid cutaneous fistula in the presence of an intrathecal drug delivery system. Anesthesiology (1994) 0.78
Spinal drug delivery. Curr Pain Headache Rep (2001) 0.77
Intrathecal granuloma complicating chronic spinal infusion of morphine. Report of three cases. J Neurosurg (1996) 0.77
Intrathecal morphine pump as a treatment option in chronic pain of nonmalignant origin. Surg Neurol (1998) 0.76
Recurrent intrathecal baclofen pump catheter leakage: A surgical observation with recommendations. J Pediatr Surg (2002) 0.76
Errors and limitations of the multimodality checking methods of defective spinal intrathecal pump systems. Case report. Paraplegia (1993) 0.75
[Not Available]. Schmerz (2000) 0.75
Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): standardized protocol and reference values. Pain (2006) 5.55
Soil fertility limits carbon sequestration by forest ecosystems in a CO2-enriched atmosphere. Nature (2001) 5.02
Guanylyl cyclases and signaling by cyclic GMP. Pharmacol Rev (2000) 4.10
A membrane form of guanylate cyclase is an atrial natriuretic peptide receptor. Nature (1989) 3.21
Selective targeting of somatostatin receptor 3 to neuronal cilia. Neuroscience (1999) 2.84
Human beta-defensin 4: a novel inducible peptide with a specific salt-sensitive spectrum of antimicrobial activity. FASEB J (2001) 2.52
The Concise Guide to PHARMACOLOGY 2013/14: overview. Br J Pharmacol (2013) 2.48
Identification of a novel, multifunctional beta-defensin (human beta-defensin 3) with specific antimicrobial activity. Its interaction with plasma membranes of Xenopus oocytes and the induction of macrophage chemoattraction. Cell Tissue Res (2001) 2.45
Evaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of tuberculosis. Eur Respir J (2008) 2.43
Intubating laryngeal mask as a ventilatory device during percutaneous dilatational tracheostomy: a descriptive study. Br J Anaesth (2007) 2.22
The release of the adipocytokine visfatin is regulated by glucose and insulin. Diabetologia (2006) 2.09
Intravenous streptokinase in evolving acute myocardial infarction. Am J Cardiol (1984) 2.08
Lactic acidosis as a serious perioperative complication of antidiabetic biguanide medication with metformin. Anesthesiology (1997) 2.05
Serum concentration of S-100 protein in assessment of cognitive dysfunction after general anesthesia in different types of surgery. Acta Anaesthesiol Scand (2002) 2.02
Hemisensory impairment in patients with complex regional pain syndrome. Pain (1999) 1.90
Human sodium channel myotonia: slowed channel inactivation due to substitutions for a glycine within the III-IV linker. J Physiol (1993) 1.90
Bilateral motor cortex disinhibition in complex regional pain syndrome (CRPS) type I of the hand. Neurology (2003) 1.86
[Ethic charter of the German Society for the Study of Pain (DGSS)]. Schmerz (2008) 1.83
Vascular abnormalities in acute reflex sympathetic dystrophy (CRPS I): complete inhibition of sympathetic nerve activity with recovery. Arch Neurol (1999) 1.78
How knowledge drives understanding--matching medical ontologies with the needs of medical language processing. Artif Intell Med (1999) 1.75
Plasma concentration of bupivacaine after stellate ganglion blockade. Anesth Analg (1991) 1.67
Long-term oral opioid therapy in patients with chronic nonmalignant pain. J Pain Symptom Manage (1992) 1.66
Mutation analysis for RUNX1, MLL-PTD, FLT3-ITD, NPM1 and NRAS in 269 patients with MDS or secondary AML. Leukemia (2010) 1.65
[Pain treatment facilities in Germany. Ambulatory, day care and inpatient facilities for patients with chronic pain]. Schmerz (2004) 1.61
Aspirin and clopidogrel with or without phenprocoumon after drug eluting coronary stent placement in patients on chronic oral anticoagulation. J Intern Med (2008) 1.60
Bilateral somatosensory cortex disinhibition in complex regional pain syndrome type I. Neurology (2011) 1.57
Randomised trial of three rapamycin-eluting stents with different coating strategies for the reduction of coronary restenosis: 2-year follow-up results. Heart (2009) 1.55
Vasopressin improves vital organ blood flow after prolonged cardiac arrest with postcountershock pulseless electrical activity in pigs. Crit Care Med (1999) 1.53
Frequency of very low HCV viremia detected by a highly sensitive HCV-RNA assay. J Clin Virol (2007) 1.51
C-terminal splice variants of the mouse mu-opioid receptor differ in morphine-induced internalization and receptor resensitization. J Biol Chem (2001) 1.50
DG3173 (somatoprim), a unique somatostatin receptor subtypes 2-, 4- and 5-selective analogue, effectively reduces GH secretion in human GH-secreting pituitary adenomas even in Octreotide non-responsive tumours. Eur J Endocrinol (2011) 1.48
Guanylyl cyclase C agonists regulate progression through the cell cycle of human colon carcinoma cells. Proc Natl Acad Sci U S A (2001) 1.47
Operant conditioning of heart rate in patients with premature ventricular contractions. Psychosom Med (1971) 1.46
[Structure of outpatient pain therapy in Germany. Results of a survey]. Schmerz (2008) 1.46
Erythropoietin-induced progenitor cell mobilisation in patients with acute ST-segment-elevation myocardial infarction and restenosis. Thromb Haemost (2012) 1.45
[German Acupuncture Trials (gerac) address problems of methodology associated with acupuncture studies]. Schmerz (2005) 1.45
Laser heat hyperalgesia is not a feature of non-specific chronic low back pain. Eur J Pain (2014) 1.45
Direct conversion from oral morphine to transdermal fentanyl: a multicenter study in patients with cancer pain. Pain (1996) 1.44
Simulation of arterial hemodynamics after partial prosthetic replacement of the aorta. Ann Thorac Surg (1999) 1.44
Carboxyl-terminal splicing of the rat mu opioid receptor modulates agonist-mediated internalization and receptor resensitization. J Biol Chem (1998) 1.43
Low-density lipoprotein receptor-related protein in atherosclerosis development: up-regulation of gene expression in patients with coronary obstruction. J Mol Med (Berl) (1998) 1.43
[The pilot project "Soteria Bern" in treatment of acute schizophrenic patients. I. Conceptual principles, practical realization, clinical experiences]. Nervenarzt (1991) 1.41
[Dealing with the medicine of deceased hospice clients in Germany]. Schmerz (2006) 1.40
Upper airway collapsibility and cephalometric variables in patients with obstructive sleep apnea. Am J Respir Crit Care Med (2000) 1.39
[Principles of chronic pain therapy with opioids. Results of a Sertürner workshop "Chronic Opioid Therapy"]. Anaesthesist (1995) 1.39
Influence of coronary angioplasty on the progression of coronary atherosclerosis. Am J Cardiol (1995) 1.39
Peripheral blood mononuclear cells isolated from patients with diabetic nephropathy show increased activation of the oxidative-stress sensitive transcription factor NF-kappaB. Diabetologia (1999) 1.38
Low-dose surfactant instillation during extracorporeal membrane oxygenation therapy in a patient with adult respiratory distress syndrome and secondary atelectasis after chest contusion. J Cardiothorac Vasc Anesth (2000) 1.38
Towards a broad-coverage biomedical ontology based on description logics. Pac Symp Biocomput (2003) 1.37
Molecular recognition by self-assembled monolayers of cavitand receptors. Science (1994) 1.37
Patterning of the R7 and R8 photoreceptor cells of Drosophila: evidence for induced and default cell-fate specification. Development (1999) 1.36
[Recommendations on classification of German pain treatment services]. Schmerz (2011) 1.36
Immunohistochemical determination of five somatostatin receptors in meningioma reveals frequent overexpression of somatostatin receptor subtype sst2A. Clin Cancer Res (2000) 1.35
Analysis of mouse dendritic cell migration in vivo upon subcutaneous and intravenous injection. Immunology (1999) 1.35
Photo-oxidative killing of human colonic cancer cells using indocyanine green and infrared light. Br J Cancer (1999) 1.33
Homo- and heterodimerization of somatostatin receptor subtypes. Inactivation of sst(3) receptor function by heterodimerization with sst(2A). J Biol Chem (2000) 1.33
Circulating vascular cell adhesion molecule-1 correlates with the extent of human atherosclerosis in contrast to circulating intercellular adhesion molecule-1, E-selectin, P-selectin, and thrombomodulin. Arterioscler Thromb Vasc Biol (1997) 1.30
Cost analysis of a hospital-wide selective screening programme for methicillin-resistant Staphylococcus aureus (MRSA) carriers in the context of diagnosis related groups (DRG) payment. Clin Microbiol Infect (2005) 1.28
The paracrine hormone hypothesis of colorectal cancer. Clin Pharmacol Ther (2007) 1.26
Pharyngeal critical pressure in patients with obstructive sleep apnea syndrome. Clinical implications. Am J Respir Crit Care Med (1999) 1.24
Discourse structures in medical reports--watch out! The generation of referentially coherent and valid text knowledge bases in the MEDSYNDIKATE system. Int J Med Inform (1999) 1.24
The nature of four bilirubin fractions from serum and of three bilirubin fractions from bile. J Lab Clin Med (1966) 1.23
[Do politicians feel pain?]. Schmerz (2003) 1.19
Guanylyl cyclase C is an N-linked glycoprotein receptor that accounts for multiple heat-stable enterotoxin-binding proteins in the intestine. J Biol Chem (1993) 1.19
[Characterization of chronic pain patients in German pain centers : core data from more than 10,000 patients]. Schmerz (2009) 1.17
Activation of polyubiquitin gene expression during developmentally programmed cell death. Neuron (1990) 1.17
MedSynDiKATe--design considerations for an ontology-based medical text understanding system. Proc AMIA Symp (2000) 1.17
Analysis of the functional role of cGMP-dependent protein kinase in intact human platelets using a specific activator 8-para-chlorophenylthio-cGMP. Biochem Pharmacol (1992) 1.17
Targeted disruption of the orphanin FQ/nociceptin gene increases stress susceptibility and impairs stress adaptation in mice. Proc Natl Acad Sci U S A (1999) 1.17
Antiplatelet effects of clopidogrel and bleeding in patients undergoing coronary stent placement. J Thromb Haemost (2009) 1.17
Vascular abnormalities in reflex sympathetic dystrophy (CRPS I): mechanisms and diagnostic value. Brain (2001) 1.16
[Recommendations of the updated LONTS guidelines. Long-term opioid therapy for chronic noncancer pain]. Schmerz (2015) 1.16
Lumbar neurolytic sympathetic blockades provide immediate and long-lasting improvement of painless walking distance and muscle metabolism in patients with severe peripheral vascular disease. J Pain Symptom Manage (1995) 1.15
[Validation of the German Mainz Pain Staging System in different pain syndromes]. Schmerz (2003) 1.14
Identification of the receptor for erythropoietin on human and murine erythroleukemia cells and modulation by phorbol ester and dimethyl sulfoxide. Proc Natl Acad Sci U S A (1988) 1.13
Characterization of the nucleoside-binding site inside the Tsx channel of Escherichia coli outer membrane. Reconstitution experiments with lipid bilayer membranes. Eur J Biochem (1988) 1.13
Preoperative alpha2-adrenergic receptor agonists prevent the deterioration of renal function after cardiac surgery: results of a randomized, controlled trial. Crit Care Med (1996) 1.11
Guanylyl cyclase is an ATP sensor coupling nitric oxide signaling to cell metabolism. Proc Natl Acad Sci U S A (2003) 1.11
Long-term treatment of cancer pain with transdermal fentanyl. J Pain Symptom Manage (1998) 1.11
Dissociated loss of cold and warm sensibility during regional anaesthesia. Pflugers Arch (1974) 1.10
MorphoSaurus--design and evaluation of an interlingua-based, cross-language document retrieval engine for the medical domain. Methods Inf Med (2005) 1.09
Molecular cloning of Drosophila Rh6 rhodopsin: the visual pigment of a subset of R8 photoreceptor cells. FEBS Lett (1997) 1.09
Quantitative sensory testing, neurophysiological and psychological examination in patients with complex regional pain syndrome and hemisensory deficits. Pain (2001) 1.09
Identification of somatostatin receptor subtypes 1, 2A, 3, and 5 in neuroendocrine tumours with subtype specific antibodies. Gut (2002) 1.08
[Epidural spinal cord stimulation for therapy of chronic pain. Summary of the S3 guidelines]. Schmerz (2011) 1.08
Prune perineum syndrome: report of a second case. Teratology (1983) 1.08
[Complex regional pain syndrome. Sympathetic reflex dystrophy and causalgia]. Schmerz (2003) 1.08
[Use of antidepressants without delay]. Schmerz (2013) 1.07
Discussion of "biomedical ontologies: toward scientific debate". Methods Inf Med (2011) 1.07
Re: Seidler A, Jänichen S, Hegewald J et al. Systematic review and quantification of respiratory cancer risk for occupational exposure to hexavalent chromium. Int Arch Occup Environ Health (2013) 1.06
[German pain questionnaire and standardised documentation with the KEDOQ-Schmerz. A way for quality management in pain therapy]. Schmerz (2012) 1.06
Calnuc, an EF-hand Ca(2+) binding protein, specifically interacts with the C-terminal alpha5-helix of G(alpha)i3. Proc Natl Acad Sci U S A (2000) 1.06
Interchanging lexical information for a multilingual dictionary. AMIA Annu Symp Proc (2005) 1.06
Dose-response effects of intravenous clonidine on stress response during induction of anesthesia in coronary artery bypass graft patients. Anesth Analg (1995) 1.06
[Visual cortex in the Tolosa-Hunt syndrome. Functional imaging for the detection of a psychogenic disorder--a case report]. Schmerz (2004) 1.05
[Complications and side effects of stellate ganglion blockade. Results of a questionnaire survey]. Anaesthesist (1992) 1.05
Involvement of mitogen-activated protein kinase in agonist-induced phosphorylation of the mu-opioid receptor in HEK 293 cells. J Neurochem (2000) 1.05